Coronavirus SARS-CoV-2 infection: treatments
Evidence-based neurology checklist on coronavirus sars-cov-2 infection: treatments: General management Isolation: this is preferably in a respiratory isolation room Manage under negative pressure: avoid positive pressure Use personal protective equipment (PPE): FFP3 respirator, gown, gloves and…
General management
- Isolation: this is preferably in a respiratory isolation room
- Manage under negative pressure: avoid positive pressure
- Use personal protective equipment (PPE): FFP3 respirator, gown, gloves and eye protection
Empirical treatments
Treatment of severe cases
Synonym
References
- Lake MA. What we know so far: COVID-19 current clinical knowledge and research. Clin Med (Lond) 2020; 20:124-127.
- Guo YR, Cao QD, Hong ZS, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status. Mil Med Res 2020; 7:11.
- Gautret P, Lagier JC, Parola P, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents 2020 (Epub ahead of print).
- Kim AHJ, Sparks JA, Liew JW, et al. A rush to judgment? Rapid reporting and dissemination of results and its consequences regarding the use of hydroxychloroquine for COVID-19. Ann Intern Med 2020; doi: 10.7326/M20-1223 (Epub ahead of print).
- Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res 2020 (Epub ahead of print).
- And 3 more. Subscribe to see the full list
Related checklists
- Coronavirus SARS-CoV-2 infection: epidemiology and prognosis
- Coronavirus SARS-CoV-2 infection: systemic features
- Coronavirus SARS-CoV-2 infection: central vascular features
- Coronavirus SARS-CoV-2 infection: central non-vascular features
- Coronavirus SARS-CoV-2 infection: cranial nerve disorders
- Coronavirus SARS-CoV-2 infection: peripheral features
- Coronavirus SARS-CoV-2 infection: neurological investigations
- Coronavirus SARS-CoV-2 infection: systemic investigations
- Coronavirus SARS-CoV-2 infection: high risk conditions
- Coronavirus SARS-CoV-2 infection: neurological disorders recommendations
- Coronavirus SARS-CoV-2 infection: multiple sclerosis (MS) recommendations
- Coronavirus SARS-CoV-2 vaccine: cerebral vein thrombosis (CVT)
- Coronavirus SARS-CoV-2 vaccine: other neurological complications
- Coronavirus SARS-CoV-2 vaccine systemic complications
- Coronavirus SARS-CoV-2 infection: long COVID